The value of early intervention in RA--a window of opportunity.
about
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceEffectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid ArthritisImpact of early diagnosis on functional disability in rheumatoid arthritis.Clinical and radiological dissociation of anti-TNF plus methotrexate treatment in early rheumatoid arthritis in routine care: results from the ABRAB studySoluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritisEconomic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece.Atherosclerosis and rheumatoid arthritis: more than a simple association.Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis.Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review.Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort.Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies.Development of Diagnostic Techniques for Early Rheumatoid Arthritis Using Positron Emission Tomography with [11C]PK11195 and [11C]Ketoprofen Tracers.Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year.The high cost of spasticity in multiple sclerosis to individuals and society.Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?Visits to rheumatologists for arthritis: the role of access to primary care physicians, geographic availability of rheumatologists, and socioeconomic status.Novel automated system for magnetic resonance imaging quantification of the inflamed synovial membrane volume in patients with juvenile idiopathic arthritis.Stratified medicine in rheumatoid arthritis-the MATURA programme.
P2860
Q28073310-4AA844B3-20BF-433E-B12C-6406ACD8AB65Q33652800-301F3EF4-CE5B-4157-B2DD-A7E67172D204Q33907199-31E27285-9851-4060-8182-797BFEF7E548Q33968506-CE4ACEDA-2FF2-45E4-A55E-ADBC2F976494Q34504787-385A950E-7880-4CAC-8DAD-447D348CC46FQ35001257-009AABBB-6F5B-424C-B87A-97BBB88F903FQ36253671-218C17B7-6D36-4A43-8799-882369E39EB4Q38024758-D51DB0CF-5707-407A-92D8-53CAF3D71905Q38105939-2B9E7C29-1160-4333-8E27-6E38A4E7CAB0Q38185644-922D4E75-5F2E-4652-8F00-1449A36FE314Q38539811-0C83E048-3996-4EB0-A707-624AB74A9861Q39041707-847401B5-701F-4E44-A831-B66AF78ADE90Q40501745-AB022F41-BD3E-433B-86ED-409DDA35F69CQ41523590-46C8C832-3281-4DA5-A848-45FFF2E4C638Q44544706-B2CACC09-C3BF-48FB-8A52-BD16D131330AQ48519138-DAC9C6F5-2F54-4165-8990-B31D3102B454Q50109641-CBB024AE-01BB-415D-89A4-FA135AD4AEE4Q51364277-27A0C9ED-2E47-44B2-8684-F60287A53EA8Q55239842-66EC3764-3EBA-4B84-82D3-DD08D1ED8E6F
P2860
The value of early intervention in RA--a window of opportunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The value of early intervention in RA--a window of opportunity.
@en
The value of early intervention in RA--a window of opportunity.
@nl
type
label
The value of early intervention in RA--a window of opportunity.
@en
The value of early intervention in RA--a window of opportunity.
@nl
prefLabel
The value of early intervention in RA--a window of opportunity.
@en
The value of early intervention in RA--a window of opportunity.
@nl
P2860
P1476
The value of early intervention in RA--a window of opportunity.
@en
P2093
Ferdinand Breedveld
P2860
P356
10.1007/S10067-010-1638-5
P478
30 Suppl 1
P577
2011-02-25T00:00:00Z